Traslational Cancer Drugs Pharma, SL Report issue

For profit Phase 1
Founded: Madrid Spain (2005)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2011
NCT01215864
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

tcd-717 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1